Viewing Study NCT05673967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-06-28 @ 8:36 PM
Study NCT ID: NCT05673967
Status: COMPLETED
Last Update Posted: 2025-04-25
First Post: 2022-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed and Refractory Multiple Myeloma (RRMM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Real-World Outcomes View
None Multiple Myeloma (MM) View
None Objective response rate (ORR) View
None Triple-class exposed (TCE) View
None Triple-class refractory (TCR) View
None Progression-free survival (PFS) View
None Overall survival (OS) View